Abiopharma

🔍 Ahlers James M (Executive)

Company: Cue Biopharma, Inc. (CUE)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 25,500 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,500.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 51,000 shares of Stock Option (Right to Buy) at $30.4 per share (Derivative)
  Date: 2026-07-30 | Code: A | Expires: 2036-07-30 | equity_swap_involved: 0 | shares_owned_after: 51,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents the grant of restricted stock units ("RSUs"). The shares subject to the RSU vest in equal quarterly installments over four years from July 30, 2026, subject to the reporting person's continued service with the issuer through each vest date.
• F2: The stock option becomes exercisable in equal quarterly installments over four years from July 30, 2026, subject to the reporting person's continued service with the issuer through each vest date.